BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11398208)

  • 1. Diagnostic and prognostic tumor markers in the gastrointestinal tract.
    Seregni E; Ferrari L; Martinetti A; Bombardieri E
    Semin Surg Oncol; 2001 Mar; 20(2):147-66. PubMed ID: 11398208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators.
    Ardill JE; O'Dorisio TM
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenes, growth factors, receptor expression and proliferation markers in digestive neuroendocrine tumours. A critical reappraisal.
    Delle Fave G; Corleto VD
    Ann Oncol; 2001; 12 Suppl 2():S13-7. PubMed ID: 11762339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumors of the gastrointestinal tract and the pancreas: histopathology, staging and prognosis.
    Hermanek P
    Anticancer Res; 1999; 19(4A):2393-6. PubMed ID: 10470164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
    Cervera P; Fléjou JF
    Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histology, histochemistry, tumor and serum markers in gastrointestinal tract cancer.
    Risio M
    Curr Opin Oncol; 1992 Aug; 4(4):714-27. PubMed ID: 1511027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis.
    Wang CJ; Zhang ZZ; Xu J; Wang M; Zhao WY; Tu L; Zhuang C; Liu Q; Shen YY; Cao H; Zhang ZG
    World J Gastroenterol; 2015 Jul; 21(27):8398-407. PubMed ID: 26217092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoplasms of the disseminated neuroendocrine cell system of the gastrointestinal tract].
    Klöppel G
    Pathologe; 2015 May; 36(3):237-45. PubMed ID: 25947223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Pathology of Gastrointestinal Stromal Tumors: Practical Implications of Morphologic and Molecular Heterogeneity for Precision Medicine.
    Charville GW; Longacre TA
    Adv Anat Pathol; 2017 Nov; 24(6):336-353. PubMed ID: 28820749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of computerized tomography in the staging of gastrointestinal neoplasms.
    Angelelli G; Ianora AA; Scardapane A; Pedote P; Memeo M; Rotondo A
    Semin Surg Oncol; 2001 Mar; 20(2):109-21. PubMed ID: 11398204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary leiomyosarcomas of the gastrointestinal tract in the post-gastrointestinal stromal tumor era.
    Aggarwal G; Sharma S; Zheng M; Reid MD; Crosby JH; Chamberlain SM; Nayak-Kapoor A; Lee JR
    Ann Diagn Pathol; 2012 Dec; 16(6):532-40. PubMed ID: 22917807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.
    Miettinen M; Majidi M; Lasota J
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S39-51. PubMed ID: 12528772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma.
    Xia B; Zhang L; Guo SQ; Li XW; Qu FL; Zhao HF; Zhang LY; Sun BC; You J; Zhang YZ
    World J Gastroenterol; 2015 Feb; 21(8):2433-42. PubMed ID: 25741152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic and molecular characteristics of malignant gastrointestinal neuroectodermal tumors].
    Zhao M; Zhao TW; Ma J; Wu CY; Chen L; Ru GQ; He XL
    Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):750-755. PubMed ID: 29136686
    [No Abstract]   [Full Text] [Related]  

  • 15. Defining disease with laser precision: laser capture microdissection in gastroenterology.
    Blatt R; Srinivasan S
    Gastroenterology; 2008 Aug; 135(2):364-9. PubMed ID: 18619446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and morphological characteristics of gastrointestinal stromal tumors].
    Khalikov DD; Akhmetzyanov FS; Petrov SV
    Arkh Patol; 2017; 79(4):48-55. PubMed ID: 28791999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNAs in gastrointestinal and liver cancers: their perspectives and clinical applications.
    Shen J; Wu WK; Ren SX; Zhang L; Chan RL; Wong CC; Lu L; Cho CH
    Curr Pharm Des; 2013; 19(7):1301-10. PubMed ID: 23092341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The importance of mutational status in prognosis and therapy of GIST].
    Comandone A; Boglione A
    Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant tumors of digestive organs and liver metastases at the time of diagnosis.
    Toader E; Drug VL; Munteanu I; Petroius D; Ciortescu I; Barboi O; Mohammad A
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):975-82. PubMed ID: 23700875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
    Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
    Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.